ctrl K

AI Score

Unlock

Tenaya Therapeutics Inc. (TNYA)

AI Score

Unlock

1.02

0.01 (0.99%)

At close: Mar 03, 2025, 12:26 PM

Tenaya Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	8.69M	8.71M	4.03M	2.48M	1.99M
Gross Profit	-8.69M	-8.71M	-4.03M	-2.48M	-1.99M
Operating Income	-131.19M	-125.62M	-72.81M	-38.91M	-27.71M
Interest Income	7.06M	1.95M	108K	87K	453K
Pretax Income	-124.08M	-123.67M	-72.72M	-38.4M	-26.23M
Net Income	-124.08M	-123.66M	-69.65M	-38.31M	-25.78M
Selling & General & Admin	33.16M	31.08M	18.41M	7.81M	4.56M
Research & Development	98.04M	94.54M	54.39M	31.1M	23.15M
Other Expenses	n/a	2K	-23K	430K	1.03M
Operating Expenses	131.19M	125.62M	72.81M	38.91M	27.71M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	131.19M	125.62M	72.81M	38.91M	27.71M
Income Tax	n/a	-1.96K	-3.07M	-87K	-453K
Shares Outstanding (Basic)	73.79M	44.82M	41.29M	41.12M	41.12M
Shares Outstanding (Diluted)	73.79M	44.82M	41.29M	41.12M	41.12M
EPS (Basic)	-1.68	-2.76	-1.69	-0.93	-0.63
EPS (Diluted)	-1.68	-2.76	-1.69	-0.93	-0.63
EBITDA	-122.51M	-114.95M	-68.7M	-36.43M	-25.72M
Depreciation & Amortization	8.69M	8.71M	4.03M	2.48M	1.99M